RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents. The company is focused on developing molecule drugs which activate the immune system to eradicate cancer. Rapt Therapeutics also elaborates novel therapies to prolong the lives of people with cancer.
|HQ||South San Francisco, CA, US||Map|
Net income (Q1, 2021)
EBIT (Q1, 2021)
Market capitalization (13-Jul-2020)
Closing stock price (13-Jul-2020)
When was RAPT Therapeutics founded?
RAPT Therapeutics was founded in 2015.
Who are RAPT Therapeutics key executives?
RAPT Therapeutics's key executives are William Ho, Rodney Young and Brian Wong.
How many employees does RAPT Therapeutics have?
RAPT Therapeutics has 64 employees.
What is RAPT Therapeutics revenue?
Latest RAPT Therapeutics annual revenue is $5 m.
What is RAPT Therapeutics revenue per employee?
Latest RAPT Therapeutics revenue per employee is $78.8 k.
Who are RAPT Therapeutics competitors?
Competitors of RAPT Therapeutics include Kiromic Biopharma, XBiotech and Dragonfly.
Where is RAPT Therapeutics headquarters?
RAPT Therapeutics headquarters is located at 561 Eccles Ave, South San Francisco.
Where are RAPT Therapeutics offices?
RAPT Therapeutics has an office in South San Francisco.
How many offices does RAPT Therapeutics have?
RAPT Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies